Filing Details

Accession Number:
0001714899-24-000122
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-05-17 16:28:33
Reporting Period:
2024-05-15
Accepted Time:
2024-05-17 16:28:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1714899 Denali Therapeutics Inc. DNLI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1197020 L Vicki Sato C/O Denali Therapeutics Inc.
161 Oyster Point Blvd.
South San Francisco CA 94080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-05-15 1,674 $20.39 116,369 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted September 27, 2023.
  2. Includes 4,216 unvested RSUs.